Respiratory Syncytial Virus (RSV) is a single-stranded RNA virus respiratory pathogen causing lower respiratory tract infections such as pneumonia, bronchiolitis, and other related diseases, prominently among the elderly, and infants. It comprises a considerable disease burden across the globe due to high infection rate. RSV infection is more prominent during the rainy season in tropical season. Lately, cases related to RSV are on the rise. To limit the spread of RSV, early detection is necessary.
MARKET DYNAMICS
Factors such as growing demand in point of care testing diagnostic test for RSV infected person and the development in field of specific markers such as proteomics and genomic will spur the demand for RSV diagnostics market. Additionally, rising neonatal population base, and increasing demand for in-vitro diagnostics will boost the market growth to significant extent over the forecast period. However, low detection of immunoassays and growing developments in RSV vaccines impede the growth of the market in the forecasted period.
MARKET SCOPE
The "Global RSV diagnostics Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of RSV diagnostics market with detailed market segmentation by on type, method, end-user and geography. The global RSV diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading RSV diagnostics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global RSV diagnostics market is segmented on product, method and end-user. Based on type, the global RSV diagnostics market is segmented into kits and assays, instruments. Based on method, the global RSV diagnostics market is segmented into rapid antigen detection test, and molecular diagnostic. Based on end user, the global RSV diagnostics market is segmented into hospitals & clinics, clinical laboratories, homecare.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global RSV diagnostics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The RSV diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting RSV diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the RSV diagnostics market in these regions.
MARKET PLAYERS
The reports cover key developments in the RSV diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from RSV diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for RSV diagnostics market in the global market. Below mentioned is the list of few companies engaged in the RSV diagnostics market.
The report also includes the profiles of key RSV diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- bioM?rieux SA
- Abbott
- F. Hoffmann-La Roche Ltd
- BD
- Thermo Fisher Scientific
- Luminex Corporation
- Danaher Corporation
- Biocartis SA
- Hologic, Inc
- Alnylam Pharmaceuticals, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.